4C. J. Wilson,H. Zhan,L. Swint-Kruse,K. S. Matthews. The lactose repressor system: paradigms for regulation, allosteric behavior and protein folding[J] 2007,Cellular and Molecular Life Sciences(1):3～16
5Kay Terpe. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems[J] 2006,Applied Microbiology and Biotechnology(2):211～222
6Namthip Chumpolkulwong,Kensaku Sakamoto,Akiko Hayashi,Fumie Iraha,Naoko Shinya,Natsuko Matsuda,Daisuke Kiga,Akiko Urushibata,Mikako Shirouzu,Kenji Oki,Takanori Kigawa,Shigeyuki Yokoyama. Translation of ‘rare’ Codons in a Cell-free Protein Synthesis System from Escherichia coli[J] 2006,Journal of Structural and Functional Genomics(1):31～36
2Bergdoll M S,Staphylococcal intoxications.In Riemann H and Bryan F L(ed),Foodborn infections and intoxications.Academic Press.Inc NewYork,1979,pp.443～493
3Fleischer B,Schrezenmeier H.T lymphocyte activation by staphylococcal enterotoxins: role of class Ⅱ molecules and T cell surface structure.Cell Immunol,1989,120(1): 92～101
4Philippa Marrack,John Kappler.The staphylococcal enterotoxins and their relatives.Science,1990,148:705～711
7Mikael.Dohlsten,Lars.Abrahmsen,PerBjork,Monoclonal antibody-superantigen fusion proteins: Tumor specific agents for T-cellbased tumor therapy.Proc Natl Acad Sci USA,1994,191:8945～8949
8Kalland T,Dohlsten M,Lind P.Monoclonal antibodies and superantigens: a novel therapeutic approach.Oncol Tumor Pharmacother,1993,10(1～2) :37～47
9Alpaugh R K,Schultz J,McAleer C.Superantigen-targeted therapy:phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies.Clin Cancer Res,1998,4(8): 1903～1914
10Marsha J,Betley,John J Mekalanos.Nucleotide Sequence of the Type A staphylococcal enterotoxin.Gene J Bacteriol,1988,170:34～43
